Search Results - Torben Nathan
- Showing 1 - 3 results of 3
-
1
-
2
Budesonide Is More Effective Than Mesalamine or Placebo in Short-term Treatment of Collagenous Colitis by Stephan Miehlke, Ahmed Madisch, Limas Kupčinskas, Dalius Petrauskas, Günter Böhm, Hans-Joachim Marks, Michael Neumeyer, Torben Nathan, Fernando Fernández‐Bañares, Roland Greinwald, Ralf Mohrbacher, Michael Vieth, Ole K. Bonderup
Published 2014Artigo -
3
Doubling the infliximab dose versus halving the infusion intervals in Crohnʼs disease patients with loss of response by Lior H. Katz, Javier P. Gisbert, Beth Manoogian, Kirk Lin, Casper Steenholdt, Gerassimos J. Mantzaris, Ashish Atreja, Yulia Ron, Arun Swaminath, Somal Shah, Ailsa Hart, Péter L. Lakatos, Pierre Ellul, Eran Israeli, Mads Naundrup Svendsen, C. Janneke van der Woude, Κωνσταντίνος Κατσάνος, Laura Yun, Epameinondas V. Tsianos, Torben Nathan, María T. Abreu, Iris Dotan, Bret A. Lashner, Jørn Brynskov, Jonathan P. Terdiman, Peter Higgins, María Chaparro, Shomron Ben–Horin
Published 2012Artigo
Search Tools:
Related Subjects
Disease
Internal medicine
Medicine
Crohn's disease
Gastroenterology
Inflammatory bowel disease
Alternative medicine
Budesonide
Capsule endoscopy
Colitis
Collagenous colitis
Confidence interval
Corticosteroid
Crohn disease
Diagnostic accuracy
Endoscopy
Infliximab
Microscopic colitis
Odds ratio
Pathology
Physics
Placebo
Quantum mechanics
Radiology
Surgery
Term (time)